Implementierungsleitfaden Therapieziele Onkologie
1.0.0-ballot - Ballot
Germany
Implementierungsleitfaden Therapieziele Onkologie - Local Development build (v1.0.0-ballot) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
{
"resourceType" : "MedicationAdministration",
"id" : "MedicationAdministrationPembroChemoNeoadjuvantMamma2",
"language" : "de",
"text" : {
"status" : "generated",
"div" : "<div xml:lang=\"de\" lang=\"de\"><hr/><p><b>German</b></p><hr/><p class=\"res-header-id\"><b>Generated Narrative: MedicationAdministration MedicationAdministrationPembroChemoNeoadjuvantMamma2</b></p><a name=\"MedicationAdministrationPembroChemoNeoadjuvantMamma2\"> </a><a name=\"hcMedicationAdministrationPembroChemoNeoadjuvantMamma2\"> </a><p><b>status</b>: Completed</p><p><b>medication</b>: <span title=\"Codes:\">Pembrolizumab + Carboplatin (q3w), Paclitaxel wöchentlich begleitend (KEYNOTE-522, Phase 1)</span></p><p><b>subject</b>: <a href=\"Patient-PatientinMamma.html\">Sabine Baumann Female, DoB: 1977-06-24</a></p><p><b>effective</b>: 2025-11-01</p><p><b>request</b>: <a href=\"MedicationRequest-MedicationRequestPembroChemoNeoadjuvantMamma.html\">MedicationRequest: extension = New LoT; status = completed; intent = plan; category = Tumor board Consult note; medication[x] = </a></p><p><b>note</b>: </p><blockquote><div><p>Zyklus 2 von 4 (Pembro/Carbo q3w); begleitend wöchentliche Paclitaxel-Gaben, hier nicht einzeln erfasst</p>\n</div></blockquote></div>"
},
"status" : "completed",
"medicationCodeableConcept" : {
"text" : "Pembrolizumab + Carboplatin (q3w), Paclitaxel wöchentlich begleitend (KEYNOTE-522, Phase 1)"
},
"subject" : {
🔗 "reference" : "Patient/PatientinMamma"
},
"effectiveDateTime" : "2025-11-01",
"request" : {
🔗 "reference" : "MedicationRequest/MedicationRequestPembroChemoNeoadjuvantMamma"
},
"note" : [
{
"text" : "Zyklus 2 von 4 (Pembro/Carbo q3w); begleitend wöchentliche Paclitaxel-Gaben, hier nicht einzeln erfasst"
}
]
}